HomeInsights52 Week High Stocks

Indoco Remedies Ltd 52 Week High

Indoco Remedies Ltd 52 Week High

stocks purchased

₹ 0.2 Cr

Volume transacted

stocks purchased

6.3 K

stocks traded

Last Updated time: 18 Sep 9.00 AM

Image

Indoco Remedies Ltd

NSE: INDOCO

YEARHIGH

416.95

Last updated: 18 Sep 24

Key Highlights

  • The 52 Week HIGH of Indoco Remedies Ltd is ₹ 416.95 as of 18 Sep 24.

Company Fundamentals for Indoco Remedies Ltd

No data available

Share price Over Time

1M

1Y

3Y

5Y

Monitoring Indoco Remedies Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Share Price

Date
leftPriceleft
18 Sep 2024369.65
17 Sep 2024375.6
16 Sep 2024366.95
13 Sep 2024371.75
12 Sep 2024373
11 Sep 2024378.25
10 Sep 2024377.85
09 Sep 2024372.55
06 Sep 2024370.75
05 Sep 2024379.8

Asset Value vs Market Value of Indoco Remedies Ltd

Market Value

0

Asset Value

0

* All values are in Rupees

Historical Revenue of Indoco Remedies Ltd

No data available

* All values are in crore

Historical Net Profit of Indoco Remedies Ltd

No data available

* All values are in crore

Indoco Remedies Ltd News Hub

News

Indoco Remedies AGM scheduled

Indoco Remedies announced that the Annual General Meeting (AGM) of the company will be hel...

Read more

31 Aug 202416:28

News

Indoco Remedies spurts on receiving USFDA nod for Lofexidine tablets

The generic equivalent of Lucemyra Tablets will market to USWM, LLC. 'Indoco has been gran...

Read more

21 Aug 202413:12

News

Indoco Remedies receives USFDA approval for Lofexidine Tablets 0.18 mg

Indoco Remedies announced the receipt of final approval from the USFDA for Abbreviated New...

Read more

21 Aug 202419:58

News

Indoco Remedies to conduct board meeting

Indoco Remedies will hold a meeting of the Board of Directors of the Company on 23 July 20...

Read more

11 Jul 202409:31

News

Indoco Remedies receives USFDA approval for Canagliflozin and Metformin Hydrochloride Tablets

Indoco Remedies announced the receipt of tentative approval from the USFDA for Abbreviated...

Read more

07 Jun 202408:40

News

Indoco Remedies gains after receiving USFDA nod for type 2 diabetes drug

Canagliflozin and Metformin Hydrochloride Tablets are used to treat type 2 diabetes mellit...

Read more

06 Jun 202414:47

Document

Annual Reports

N/A

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

FAQs for 52 Week High of Indoco Remedies Ltd

What is the significance of Indoco Remedies Ltd reaching its 52-week high?

Indoco Remedies Ltd reaching its 52-week high indicates strong market confidence and a positive outlook on the company's financial health and growth prospects. This milestone often reflects successful business performance and can boost investor sentiment.

Why do investors monitor Indoco Remedies Ltd 52-week high?

Investors monitor Indoco Remedies Ltd 52-week high to gauge the stock's peak performance and overall market strength, which can indicate robust financial health and growth potential. It also helps them assess if the stock is trading near its maximum value, influencing decisions on buying, holding, or selling.

Is Indoco Remedies Ltd a good buy when it hits its 52-week high?

Whether Indoco Remedies Ltd is a good buy at its 52-week high depends on various factors, including the company's future growth prospects, overall market conditions, individual investment strategies, and other important Indoco Remedies Ltd fundamentals.

What should I consider before investing in Indoco Remedies Ltd at its 52-week high?

Before investing in Indoco Remedies Ltd at its 52-week high, consider evaluating the company's recent financial performance, growth potential, and overall market conditions to ensure it aligns with your investment goals. Additionally, assess whether the stock's current valuation justifies the potential for future returns and if it fits your risk tolerance.

Can Indoco Remedies Ltd stock price continue to rise after reaching its 52-week high?

Indoco Remedies Ltd stock price can continue to rise after reaching its 52-week high if it maintains strong fiscal performance and favorable market conditions. However, future growth depends on numerous factors such as company earnings, industry trends, and broader economic conditions.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
50yearstrust

Unlimited trading at just

Rs. 399

Rs. 199*